ClinicalTrials.Veeva

Menu

Sevoflurane Induced Emergence Agitation

Y

Yeditepe University Hospital

Status and phase

Completed
Phase 4

Conditions

Emergence Agitation

Treatments

Drug: midazolam
Drug: ketamine
Drug: alfentanil

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Investigators evaluated the effect of intranasal ketamine or alfentanil addition to oral midazolam for prevention of emergence agitation.Seventy-eight, 1-8 year-old children, undergoing urological surgery with sevoflurane anesthesia was included in the study. All the children received oral midazolam 0.5 mg/kg 40 minutes before anesthesia induction then enrolled to one of the study groups, randomly. Ketamine group (Group MK; n=26) patients were given 2mg/kg intranasal ketamine whereas, alfentanil group (Group MA; n=25) were given 10microgram/kg intranasal alfentanil 8-10 min before the induction of anesthesia. Saline group (Group MS; n=27) received intranasal isotonic saline.Parental separation, mask acceptance were evaluated with a 4- point scale. Emergence agitation was evaluated with Pediatric Anesthesia Emergence Delirium score.

Enrollment

78 patients

Sex

All

Ages

1 to 8 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 1- 8 years
  • American Society of Anesthesiologist (ASA) I-II,
  • Patients undergoing procedures below the umbilicus

Exclusion criteria

  • cardiac diseases
  • pulmonary diseases
  • hepatic diseases
  • renal diseases
  • psychological or emotional disorders

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

78 participants in 3 patient groups, including a placebo group

midazolam and alfentanil
Active Comparator group
Description:
Midazolam 0.5mg/kg (oral) Alfentanil 10 microgram/kg (oral)
Treatment:
Drug: alfentanil
Drug: midazolam
midazolam and ketamine
Active Comparator group
Description:
Midazolam 0.5mg/kg (oral) Ketamine 2mg/kg (intranasal)
Treatment:
Drug: ketamine
Drug: midazolam
midazolam
Placebo Comparator group
Description:
Midazolam 0.5mg/kg
Treatment:
Drug: midazolam

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems